1. Molecular camouflage by a context-specific hydrogel as the key to unlock the potential of viral vector gene therapy.
- Author
-
Soltani Dehnavi, Shiva, Cembran, Arianna, Mahmoudi, Negar, Caballero Aguilar, Lilith M, Wang, Yi, Cheeseman, Samuel, Malagutti, Nicolo, Franks, Stephanie, Long, Benjamin, Lisowski, Leszek, Harvey, Alan R, Parish, Clare L., Williams, Richard J., and Nisbet, David R.
- Subjects
- *
GENETIC vectors , *GENE therapy , *VIRAL genes , *RECOMBINANT viruses , *ADENO-associated virus , *BIOMATERIALS - Abstract
[Display omitted] Gene therapy offers hope for currently untreatable diseases; the patient's own cellular machinery is recruited to create therapeutics. However, unpredictable responses that lead to neutralization by the host immune system and issues in constraining, controlling and sustaining delivery have presented clinical barriers to otherwise promising therapeutic developments. Here, we show that the protective environment provided by advanced biomaterials can function as injectable gene carriers to focus their therapeutic potential. Firstly, we investigated the potential of a tissue-specific molecular hydrogel to package recombinant adeno-associated viruses (rAAVs). Once a delivery pathway was confirmed, a set of rAAV variants were subsequently assessed for their ability to transduce various types of rodent and human neural cells in vitro and in vivo. Based on GFP expression, we identified a relatively new variant, rAAV-DJ, as showing desirable characteristics for constrained delivery and transduction efficiency. For the first time, we demonstrated precise control over the strength and type of interaction between biomaterials and rAAVs enabling the programmed release of viral payloads. This new approach enables specific infection of desired anatomical targets in a programmed fashion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF